Systems biology of interstitial lung diseases: integration of mRNA and microRNA expression changes.
BACKGROUND
The molecular pathways involved in the interstitial lung diseases (ILDs) are poorly understood. Systems biology approaches, with global expression data sets, were used to identify perturbed gene networks, to gain some understanding of the underlying mechanisms, and to develop specific hypotheses relevant to these chronic lung diseases.


METHODS
Lung tissue samples from patients with different types of ILD were obtained from the Lung Tissue Research Consortium and total cell RNA was isolated. Global mRNA and microRNA were profiled by hybridization and amplification-based methods. Differentially expressed genes were compiled and used to identify critical signaling pathways and potential biomarkers. Modules of genes were identified that formed a regulatory network, and studies were performed on cultured cells in vitro for comparison with the in vivo results.


RESULTS
By profiling mRNA and microRNA (miRNA) expression levels, we found subsets of differentially expressed genes that distinguished patients with ILDs from controls and that correlated with different disease stages and subtypes of ILDs. Network analysis, based on pathway databases, revealed several disease-associated gene modules, involving genes from the TGF-β, Wnt, focal adhesion, and smooth muscle actin pathways that are implicated in advancing fibrosis, a critical pathological process in ILDs. A more comprehensive approach was also adapted to construct a putative global gene regulatory network based on the perturbation of key regulatory elements, transcription factors and microRNAs. Our data underscores the importance of TGF-β signaling and the persistence of smooth muscle actin-containing fibroblasts in these diseases. We present evidence that, downstream of TGF-β signaling, microRNAs of the miR-23a cluster and the transcription factor Zeb1 could have roles in mediating an epithelial to mesenchymal transition (EMT) and the resultant persistence of mesenchymal cells in these diseases.


CONCLUSIONS
We present a comprehensive overview of the molecular networks perturbed in ILDs, discuss several potential key molecular regulatory circuits, and identify microRNA species that may play central roles in facilitating the progression of ILDs. These findings advance our understanding of these diseases at the molecular level, provide new molecular signatures in defining the specific characteristics of the diseases, suggest new hypotheses, and reveal new potential targets for therapeutic intervention.
Institute for Systems Biology, Seattle, WA, USA.
Ji-Hoon
JH
Cho
Richard
R
Gelinas
Kai
K
Wang
Alton
A
Etheridge
Melissa G
MG
Piper
Kara
K
Batte
Duaa
D
Dakhallah
Jennifer
J
Price
Dan
D
Bornman
Shile
S
Zhang
Clay
C
Marsh
David
D
Galas
D000328:Adult; D000368:Aged; D016022:Case-Control Studies; D002478:Cells, Cultured; D005260:Female; D053263:Gene Regulatory Networks; D006801:Humans; D017563:Lung Diseases, Interstitial / Q000235:genetics* / Q000378:metabolism; D008297:Male; D035683:MicroRNAs / Q000235:genetics / Q000378:metabolism*; D008875:Middle Aged; D012333:RNA, Messenger / Q000032:analysis / Q000235:genetics / Q000378:metabolism*; D015398:Signal Transduction / Q000235:genetics; D012984:Software; D049490:Systems Biology
D035683:MicroRNAs; D012333:RNA, Messenger
Genome Biol. 2009;10(3):R29
19284633
Mol Cell. 2009 Nov 13;36(3):457-68
19917253
J Thorac Oncol. 2009 Aug;4(8):1028-34
19474765
Cell. 2008 Mar 7;132(5):875-86
18329372
Clin Cancer Res. 2009 Aug 15;15(16):5060-72
19671845
Genes Dev. 2008 Apr 1;22(7):894-907
18381893
Brief Funct Genomic Proteomic. 2008 Jul;7(4):239-48
18579616
Am J Pathol. 2003 May;162(5):1495-502
12707032
Am J Respir Cell Mol Biol. 2006 Jun;34(6):727-37
16474099
Curr Opin Pharmacol. 2009 Aug;9(4):514-20
19525145
Sci China C Life Sci. 2009 Dec;52(12):1123-30
20016969
Am J Respir Crit Care Med. 2006 Jan 15;173(2):141-2
16391303
Biochem J. 2005 Mar 15;386(Pt 3):461-70
15496141
Proc Natl Acad Sci U S A. 2000 Feb 15;97(4):1778-83
10677534
Am J Respir Crit Care Med. 2009 Jan 1;179(1):4-10
18787215
PLoS Comput Biol. 2006 Dec 22;2(12):e169
17194216
Semin Diagn Pathol. 2007 Aug;24(3):183-7
17882901
Eur Respir J. 1997 Apr;10(4):822-7
9150319
Nurs Times. 2005 Jun 21-27;101(25):58-61
15997954
Chest. 2005 Nov;128(5 Suppl 1):526S-532S
16304243
BMC Bioinformatics. 2007 Jan 24;8:22
17250769
Phys Biol. 2005 Jun;2(2):81-8
16204860
Am J Respir Crit Care Med. 2002 Jul 15;166(2):236-46
12119236
PLoS Med. 2008 Mar 4;5(3):e62
18318599
J Biol Chem. 2005 Mar 18;280(11):10861-9
15657056
ScientificWorldJournal. 2008 Sep 21;8:901-4
18836656
Biochem Soc Trans. 2008 Dec;36(Pt 6):1224-31
19021530
Proc Natl Acad Sci U S A. 2009 Mar 17;106(11):4402-7
19246379
Nat Genet. 2006 Jun;38 Suppl:S20-4
16736020
Yi Chuan. 2009 Nov;31(11):1149-57
19933097
Neurobiol Dis. 2010 May;38(2):148-53
19765659
Science. 2004 Oct 22;306(5696):640-3
15499008
Cytokine. 2008 Sep;43(3):391-4
18701320
J Clin Invest. 2001 Jun;107(12):1537-44
11413161
Am J Pathol. 2005 May;166(5):1321-32
15855634
Cancer Res. 2005 Nov 1;65(21):9628-32
16266980
Am J Respir Crit Care Med. 2010 Jul 15;182(2):220-9
20395557
Brief Bioinform. 2006 Dec;7(4):390-8
17000735
Transl Res. 2008 Apr;151(4):175-80
18355764
Recent Pat DNA Gene Seq. 2009;3(2):77-87
19519577
PLoS One. 2009;4(5):e5540
19436744
Am J Respir Crit Care Med. 2005 Aug 1;172(3):268-79
15879420
Nat Cell Biol. 2008 May;10(5):593-601
18376396
Development. 2008 Feb;135(3):579-88
18192284
Semin Oncol. 2009 Dec;36(6):553-65
19995647
Nat Biotechnol. 2004 Jun;22(6):656-8; author reply 658
15175677
J Hum Genet. 2008;53(6):515
18465083
Proc Am Thorac Soc. 2006 Jun;3(4):364-72
16738202
Bioinformatics. 2005 Oct 15;21(20):3896-904
16105897
J Biol Chem. 2008 May 30;283(22):14910-4
18411277
Bioinformatics. 2003 Jan 22;19(2):185-93
12538238
PLoS Med. 2005 Sep;2(9):e251
16128620